Immunome (IMNM) FCF Margin (2023 - 2025)

Immunome (IMNM) reported FCF Margin of 1247.72% for Q2 2025, down 29726.0% on a YoY basis from N/an in Q2 2024, and up 31.95% quarter-over-quarter from 1833.46% in Q1 2025.

Immunome (IMNM) FCF Margin (2023 - 2025) Analysis & Trends

Immunome has reported FCF Margin for 3 years, with the latest figure at 1247.72% in Q2 2025.

  • For the quarter ending Q2 2025, FCF Margin fell 29726.0% year-over-year to 1247.72%; the trailing twelve-month figure through Mar 2026 stood at 4932.68% (down 352554.0% YoY), and the FY2025 full-year result was 2765.09%, down 150859.0% from the prior year.
  • FCF Margin for Q2 2025 stood at 1247.72%, up from 1833.46% in the prior quarter.
  • The five-year high for FCF Margin was 1018.06% in Q1 2023, with the low at 1833.46% in Q1 2025.
  • Historically, FCF Margin has averaged 792.75% across 3 years, with a median of 1050.35% in 2024.
  • Annual changes were most pronounced in 2024 — FCF Margin slumped 231388 bps — and 2025, when it plunged 29726 bps.
  • Immunome's FCF Margin stood at 465.45% in 2023, then sank by 248 bps to 1618.88% in 2024, then gained by 23 bps to 1247.72% in 2025.
  • The last three FCF Margin figures came in at 1247.72% (Q2 2025), 1833.46% (Q1 2025), and 1618.88% (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Immunome 2.12 Bn 1.54 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,247.72%
Mar 31, 2025 -1,833.46%
Dec 31, 2024 -1,618.88%
Sep 30, 2024 -1,150.24%
Jun 30, 2024 -950.47%
Mar 31, 2024 -1,295.82%
Dec 31, 2023 -465.45%
Sep 30, 2023 -242.64%
Jun 30, 2023 -140.93%
Mar 31, 2023 1,018.06%